Related Experiment Videos
Low-dosage heparin in rapidly progressive glomerulonephritis
Archives of Internal Medicine
|September 1, 1976
Summary
Low-dose heparin infusion effectively treated acute renal failure in two patients with rapidly progressive glomerulonephritis (RPGN). This approach arrested disease progression and improved kidney function without causing bleeding complications.
Area of Science:
- Nephrology
- Internal Medicine
- Rheumatology
Background:
- Rapidly progressive glomerulonephritis (RPGN) is a severe kidney disease often leading to acute renal failure.
- Treatment challenges include managing renal function decline and avoiding complications.
Observation:
- Two patients presented with acute renal failure and biopsy-confirmed RPGN.
- Initial symptoms included significantly reduced creatinine clearance and oliguria in one patient.
Findings:
- Treatment with low-dose heparin infusion, prednisone, warfarin, and dipyridamole led to improved creatinine clearance (≥60 ml/min) in both patients.
- Repeat biopsies showed no active glomerulonephritis, indicating disease arrest.
- No bleeding complications were observed during low-dose heparin therapy.
Implications:
- Low-dose heparin infusion offers a potentially safer alternative for managing RPGN-associated renal failure.
- This therapeutic strategy may arrest and partially reverse kidney damage in RPGN.
- Further research is warranted to confirm the efficacy and safety of this treatment regimen.